TABLE IV -.
Antibiotic susceptibility profiles of Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae
| Antibiotics | E. coli | P. mirabilis | K. pneumoniae | |||
|---|---|---|---|---|---|---|
| S% | R% | S% | R% | S% | R% | |
| Amoxicillin | 0 | 49 (100) | 0 | 15 (100) | 0 | 13 (100) |
| Amoxi + clavulanic acid | 4 (8.2) | 45 (91.8) | 0 | 15 (100) | 2 (15.4) | 11 (84.6) |
| Piperacillin | 0 | 49 (100) | 0 | 15 (100) | 0 | 13 (100) |
| Piperacillin + tazobactam | 46 (93.9) | 3 (6.1) | 12 (80) | 3 (20) | 10 (76.9) | 3 (23.1) |
| Ticarcillin | 0 | 49 (100) | 2 (13.3) | 13 (86.7) | 0 | 13 (100) |
| Aztreonam | 46 (93.9) | 3 (6.1) | 11 (73.3) | 4 (26.7) | 12 (92.3) | 1 (7.7) |
| C2G | 4 (8.2) | 45 (91.8) | 0 | 15 (100) | 3 (23.1) | 10 (76.9) |
| C3G | 4 (8.2) | 45 (91.8) | 2 (13.3) | 13 (86.7) | 5 (38.5) | 8 (61.5) |
| Cefoxitin | 32 (65.3) | 17 (34.7) | 0 | 15 (100) | 7 (53.8) | 6 (46.2) |
| Ertapenem | 48 (98.0) | 1 (2.0) | 14 (88.2) | 1 (6.7) | 11 (84.6) | 2 (15.3) |
| Imipenem | 46 (93.9) | 3 (6.1) | 11 (73.3) | 4 (26.7) | 11 (84.6) | 2 (15.3) |
| Amikacin | 39 (79.6) | 10 (20.4) | 10 (66.7) | 5 (33.3) | 9 (69.2) | 4 (30.8) |
| Gentamicin | 12 (24.5) | 37 (75.5) | 2 (13.3) | 13 (86.7) | 5 (38.5) | 8 (61.5) |
| Tobramycin | 13 (26.5) | 36 (73.5) | 2 (13.3) | 13 (86.7) | 5 (38.5) | 8 (61.5) |
| Ciprofloxacin | 5 (10.2) | 44 (89.8) | 6 (40) | 9 (60) | 4 (30.7) | 9 (69.2) |
| Trimethoprim + sulfamethoxazole | 2 (4.1) | 47 (95.9) | 6 (40) | 9 (60) | 3 (23.1) | 10 (76.9) |